Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542

Japan

Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

EP Vantage - Brexit: Laying Out a Path for UK Healthcare

  

Download Report

This report contains a series of articles published by EP Vantage looking at the implications of Brexit for the life science industries.

They highlight the most important issues for the sector, which include the future of drug and medical device regulation outside of European frameworks and implications for intellectual property.

Highlights

  • What Brexit means for life science funding and strategy
  • The UK by numbers
  • What Brexit means for drug regulation
  • What Brexit means for medtech regulation
  • What Brexit means for medtech patents

Download Report

EP Vantage is an independent editorial team providing daily commentary and analysis that allows our readers to quickly understand what is important and why. Our high quality, data-driven analysis is trusted, insightful and thought provoking, enabling our readers to make informed decisions.


    Confirm your details on form below to download this report